Literature DB >> 15031167

Why is squint surgery in children in decline?

C J MacEwen1, H S Chakrabarti.   

Abstract

BACKGROUND: /aims: Paediatric squint surgery appears to be declining. This study aims to identify if this is so and, if so, why.
METHODS: Retrospective review of (1) episodes of paediatric squint surgery in Scotland and Tayside, 1986-2001, (2) presentations to orthoptists (Tayside) during 1986 and 1996.
RESULTS: (1) Overall, a 58% fall in surgery in Scotland and 59% in Tayside. For esotropia, a reduction of 63% (Scotland) and 69% (Tayside). (2) Incidence of esotropia was unchanged; surgery for these esotropes fell (from 55% to 30%) (p = 0.013). More children received maximum hypermetropic correction (p <0.001) and more developed stereopsis (p = 0.003).
CONCLUSION: Childhood strabismus surgery, particularly for esotropia, is declining. The maximum hypermetropic correction has improved the functional results.

Entities:  

Mesh:

Year:  2004        PMID: 15031167      PMCID: PMC1772085          DOI: 10.1136/bjo.2002.016618

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  8 in total

1.  Unexpected beneficial effects of measles immunisation. Number of squint operations has decreased.

Authors:  R Finlay
Journal:  BMJ       Date:  2000-04-01

Review 2.  Screening and surveillance for ophthalmic disorders and visual deficits in children in the United Kingdom.

Authors:  J S Rahi; C Williams; H Bedford; D Elliman
Journal:  Br J Ophthalmol       Date:  2001-03       Impact factor: 4.638

3.  Refractive accommodative esotropia: a surgical problem?

Authors:  G K von Noorden; C W Avilla
Journal:  Int Ophthalmol       Date:  1992-01       Impact factor: 2.031

4.  Is the incidence of constant esotropia in childhood reducing?

Authors:  C V Carney; D A Lysons; J V Tapley
Journal:  Eye (Lond)       Date:  1995       Impact factor: 3.775

5.  Outcome in refractive accommodative esotropia.

Authors:  A Mulvihill; A MacCann; I Flitcroft; M O'Keefe
Journal:  Br J Ophthalmol       Date:  2000-07       Impact factor: 4.638

6.  Early-onset accommodative esotropia.

Authors:  J D Baker; M M Parks
Journal:  Am J Ophthalmol       Date:  1980-07       Impact factor: 5.258

7.  [Benefits of total hypermetropia correction in patients with strabismus].

Authors:  V Paris; C Andris; A Moutschen
Journal:  Bull Soc Belge Ophtalmol       Date:  1995

8.  Ophthalmology in the Oxford region: analysis of time trends from linked statistics.

Authors:  J A Ferguson; M J Goldacre; J Henderson; A J Bron
Journal:  Eye (Lond)       Date:  1991       Impact factor: 3.775

  8 in total
  6 in total

1.  Decreasing strabismus surgery.

Authors:  A Arora; B Williams; A K Arora; R McNamara; J Yates; A Fielder
Journal:  Br J Ophthalmol       Date:  2005-04       Impact factor: 4.638

2.  Nationwide study of hospitalization and surgical treatment for childhood strabismus in Italy between 1999 and 2004.

Authors:  Benedetto Ricci; Giovanni Coppola; Valentina Ricci; Lucia Ziccardi
Journal:  Int Ophthalmol       Date:  2008-03-13       Impact factor: 2.031

3.  A retrospective study of strabismus surgery in a tertiary eye hospital in the Chaoshan area in China from 2014 to 2020.

Authors:  Yu Bi; Jason C Yam; Shibin Lin
Journal:  BMC Ophthalmol       Date:  2022-06-04       Impact factor: 2.086

4.  Comitant strabismus: Perspectives, present and future.

Authors:  Darren T Oystreck; Christopher J Lyons
Journal:  Saudi J Ophthalmol       Date:  2012-05-23

5.  Is the incidence of infantile esotropia declining?: a population-based study from Olmsted County, Minnesota, 1965 to 1994.

Authors:  Curtis R Louwagie; Nancy N Diehl; Amy E Greenberg; Brian G Mohney
Journal:  Arch Ophthalmol       Date:  2009-02

Review 6.  Exotropia Is the Main Pattern of Childhood Strabismus Surgery in the South of China: A Six-Year Clinical Review.

Authors:  Xinping Yu; Zhouduo Ji; Huanyun Yu; Meiping Xu; Jinling Xu
Journal:  J Ophthalmol       Date:  2016-02-28       Impact factor: 1.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.